๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intra-arterial BCNU in the treatment of recurrent medulloblastoma

โœ Scribed by Kjell Watne; Bjarne Hager; Henry Hirschberg


Publisher
Springer US
Year
1990
Tongue
English
Weight
430 KB
Volume
8
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Two patients with recurrent medulloblastomas were treated with combined oral and intra-venous chemotherapy followed by intra-arterial BCNU. The 7 days course of oral and intra-venous chemotherapy consisted of CCNU and Procarbazin orally and Vincristine intra-venously (PCV), repeated after 6 weeks.

Intra-arterial chemotherapy consisted of 4 cycles of BCNU. Both patients responded well to treatment, evaluated by CT scans. One of the patients died of a new local recurrence 6 months after initiation of chemotherapy, whereas the other patient remains well, without CT evidence of tumour 36 months after the start of the treatment. No serious adverse side-effects related to the treatment were seen.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of recurrent esthesioneuroblas
โœ Kjell Watnel; Bjarne Hager ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer US ๐ŸŒ English โš– 928 KB

A 65 year old woman presented with a recurrent locally advanced esthesioneuroblastoma. She had earlier been treated with radiation followed by surgery. The recurrence was located in earlier radiated tissues with intracranial infiltration. She underwent treatment with combined intra-arterial chemothe

Complications associated with intra-arte
โœ Alfonso M Bremer; Enrique Kleriga; Tai Q Nguyen; Raymond Balsys; H Martin Northu ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer US ๐ŸŒ English โš– 301 KB

We have used intra-arterial (i.a.) 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) either alone or as part of adjuvant chemotherapy in patients with malignant brain tumors over a 3 year period (1979-1982). The i.a. BCNU technique was used 111 times to infuse 134 arteries in 37 patients. These patients,

Intra-arterial cisplatin for the treatme
โœ Herbert B. Newton; Michaelyn A. Page; Larry Junck; Harry S. Greenberg ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer US ๐ŸŒ English โš– 571 KB

Cisplatin (DDP) is a chemotherapeutic agent that has shown efficacy against primary CNS malignancies. Intraarterial (IA) administration of DDP to patients with brain tumors should produce higher peak levels of drug than intravenous (IV) administration of an identical dose and reduce systemic toxicit